Prescription Pricing for the People Act of 2025 mandates the Federal Trade Commission to study pharmaceutical supply chain intermediaries.
The Prescription Pricing for the People Act of 2025 requires the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain. The study will cover pharmacy benefit managers and pharmacy services administrative organizations. The Commission must submit an interim report within 180 days and a final report within one year. The final report will address issues such as pricing disparities, patient steering, data use, and formulary designs.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.